Xavier Paolettí
- Statistics and Probability top 0.5%
- Statistical Methods in Clinical Trials 57
- Oncology top 2%
- Colorectal Cancer Treatments and Studies 13
- Cancer Immunotherapy and Biomarkers 13
- Cancer Research top 2%
- Cancer Genomics and Diagnostics 30
-
- Optimal Experimental Design Methods 17
- Hepatology top 5%
-
- Health Systems, Economic Evaluations, Quality of Life 25
-
- Ovarian cancer diagnosis and treatment 16
-
- Lung Cancer Treatments and Mutations 16
- Co-authors
- Christophe Le TourneauJohn O’QuigleyVincent ServoisMarie AltDelphine LoiratTomasz BurzykowskiBirgit GeoergerVirginia Palomar Coloma
- Journals
- Journal of Clinical Oncology (18 papers)European Journal of Cancer (15 papers)Annals of Oncology (12 papers)
- Partner nations
- FranceUnited KingdomBelgium
In The Last Decade
Xavier Paolettí
146 papers receiving 4.0k citations
Hit Papers
Peers
Comparison fields: 5 of 131
- Statistics and Probability 906
- Oncology 1.4k
- Cancer Research 685
- Management Science and Operations Research 346
- Hepatology 200
Countries citing papers authored by Xavier Paolettí
This map shows the geographic impact of Xavier Paolettí's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xavier Paolettí with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xavier Paolettí more than expected).
Fields of papers citing papers by Xavier Paolettí
This network shows the impact of papers produced by Xavier Paolettí. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xavier Paolettí. The network helps show where Xavier Paolettí may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xavier Paolettí, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 9 | |
| 3 | 2022 | 3 | |
| 4 | 2022 | 13 | |
| 5 | 2021 | 36 | |
| 6 | 2021 | 11 | |
| 7 | 2021 | 3 | |
| 8 | 2021 | 24 | |
| 9 | 2021 | 24 | |
| 10 | 2020 | 1 | |
| 11 | 2018 | 4 | |
| 12 | 2018 | 9 | |
| 13 | Hyperprogression during anti-PD-1/PD-L1 therapy in patients with recurrent and/or metastatic head and neck squamous cell carcinomabreakdown → | 2017 | 449 |
| 14 | 2016 | 11 | |
| 15 | 2015 | 1 | |
| 16 | 2014 | 60 | |
| 17 | 2013 | 0 | |
| 18 | 2012 | 164 | |
| 19 | 2006 | 21 | |
| 20 | 2004 | 60 |
About Xavier Paolettí
Xavier Paolettí is a scholar working on Statistics and Probability, Cancer Research, Oncology, Reproductive Medicine and Management Science and Operations Research, having authored 158 papers that have together received 4.1k indexed citations. Recurring topics across this work include Statistical Methods in Clinical Trials (57 papers), Cancer Genomics and Diagnostics (30 papers), Health Systems, Economic Evaluations, Quality of Life (25 papers), Optimal Experimental Design Methods (17 papers), Ovarian cancer diagnosis and treatment (16 papers), Lung Cancer Treatments and Mutations (16 papers), Colorectal Cancer Treatments and Studies (13 papers) and Cancer Immunotherapy and Biomarkers (13 papers). The work is most often cited by research in Statistics and Probability (906 citations), Oncology (1.4k citations), Cancer Research (685 citations), Management Science and Operations Research (346 citations) and Hepatology (200 citations). Xavier Paolettí has collaborated with scholars based in France, United Kingdom and Belgium. Frequent co-authors include Christophe Le Tourneau, John O’Quigley, Vincent Servois, Marie Alt, Delphine Loirat, Tomasz Burzykowski, Birgit Geoerger, Virginia Palomar Coloma, Jérôme Fayette and Esma Saâda-Bouzid. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, Annals of Oncology, International Journal of Gynecological Cancer and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.